Temasek Trust’s Catalytic Capital for Climate and Health (C3H), part of the philanthropic arm of Singapore’s sovereign wealth fund, has led a successful US$1.2 million funding round for Singaporean health-technology (healthtech) firm injewelme.
The funds will support the development of injewelme’s DeepHealthVision (DHV) technology, which aims to detect health indicators such as blood glucose, stress index, fatigue and hydration to strengthen its ability to detect climate-related stressors.
United Kingdom-based family office Richardson Family also participated in the funding round.
“Injewelme’s proprietary DHV technology allows healthcare professionals to access a patient’s vital signs,” C3H said in a statement on Wednesday.
The technology uses remote photoplethysmography (rPPG), an optical technique used to detect changes in blood circulation. This enables the technology to measure more than 20 vital health parameters such as heart rate, blood pressure, and oxygen saturation. The detection can be done in about 30 seconds with a standard camera.
C3H said that injewelme’s technology, which uses a combination of in-house software and predictive AI models, has demonstrated an “industry-leading 95 per cent detection accuracy in real-world pilots.”
“It has been involved in trials with SingHealth Polyclinics and in the private sector, and is currently being evaluated for further deployment across healthcare, eldercare, insurance and workforce safety,” the statement said. “This will include monitoring physiological stress linked to rising climate-related heat exposure.”
Injewelme was founded in 2020 in South Korea by James Moon Gee Myung, who is currently also the company’s chief executive officer. The group relocated its headquarters to Singapore in 2025.
“This financing catalyses injewelme’s mission to deliver cost-effective, proactive and data-driven health monitoring at scale,” said Moon. “Beyond one-time health snapshots, we aim to enable anyone to easily and continuously track their health in everyday life, unlocking long-term health insights and advancing AI-driven predictive, preventive care.”
“This investment from C3H, part of Temasek Trust, and Richardson Family represents more than financial backing – it marks the beginning of a long-term strategic partnership,” he added in a LinkedIn post.
C3H said the funds raised will accelerate injewelme’s customer acquisition efforts in Singapore and support its expansion into new markets within Southeast Asia.
“As a strategic partner, C3H will also support injewelme by facilitating access to partners across the Temasek Trust ecosystem and broader industry networks to help accelerate commercial deployment and inform product development,” it added.
